definiens: shall mean, with respect to an Antigen, collectively, ( a ) ABXAntibody Know - How Rights, ABX Antibody Patent Rights, ABX Oncology Know - How Rights, ABX Oncology PatentRights, ABX Other Know - How Rights, ABX Other Patent Rights, XenoMouse Know - How Rights and XenoMousePatent Rights ; ( b ) the applicable ABX Prior Antigen - Specific Know - How Rights, ABX Prior Antigen - Specific PatentRights, ABX Subsequent Antigen - Specific Know - How Rights and ABX Subsequent Antigen - Specific Patent Rights;(c ) ABX ’s rights in the applicable Collaboration Know - How Rights and Collaboration Patent Rights ; and ( d ) ABX’srights in the Additional Technology Know - How Rights and Additional Technology Patent Rights ; provided, however, that Licensed ABX IP Rights shall not include the Excluded Catalytic Antibody and Intrabody IP Rights